Genital Warts
📧 Sign up to get email alerts when something new happens for Genital Warts.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs) [Phase 2]
Phase 2 trial results summarize efficacy and safety of SR-T100 Gel for external genital warts due to Condyloma Acuminata.
-
CLINICAL_TRIALS trial_result · 2019-11-21Clinical Trial Update: Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004) [Phase 3]
Phase 3 trial update on immunogenicity and tolerability of a broad-spectrum HPV vaccine (V503-004) with completed status and results posted …
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts [Phase 3]
Phase 3 clinical trial assessing intralesional MMR vaccine, intralesional candidal antigen, and topical podophyllin for genital warts (Condy…
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Immunogenicity and Safety of Gardasil-9 and Cervarix [Phase 3]
Phase 3 trial update reporting on the immunogenicity and safety of Gardasil-9 and Cervarix HPV vaccines.
-
FDA approval · 2018-12-19FDA Approved: VEREGEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approves a supplemental application for Veregen (sinecatechins) from ANI Pharmaceuticals, Inc. This action represents a supplemental app…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-01Clinical Trial Update: A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020) [Phase 3]
Phase 3 study comparing immune response of V503 to Gardasil in 16- to 26-year-old men; completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males. [Phase 2]
Phase 2 trial evaluating immunogenicity and safety of GlaxoSmithKline's HPV vaccine in young males has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Cantharone for the Treatment of Perenial Warts [Phase 4]
Phase 4 clinical trial update for Cantharone in the treatment of genital warts has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts [Phase 1, Phase 2]
A Phase 1/2 safety and efficacy study of topical AP611074 Gel for treating genital warts has completed.
-
CLINICAL_TRIALS research · 2018-04-24Clinical Trial Update: Adolescent Vaccination in Pharmacies
A completed UNC-Chapel Hill clinical trial evaluated attitudes toward HPV vaccinations in pharmacies and the feasibility of providing HPV va…
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response [Phase 3]
Phase 3 trial update evaluating whether the quadrivalent HPV vaccine reduces relapses of genital warts after initial therapeutic response.
-
CLINICAL_TRIALS trial_result · 2018-02-13Clinical Trial Update: Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9 [Phase 3]
Phase 3 trial update evaluating immunogenicity of one dose of Gardasil and one dose of Gardasil-9.
-
CLINICAL_TRIALS research · 2017-05-17Clinical Trial Update: Comparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart Patients [Phase 3]
This document provides an update on a Phase 3 clinical trial comparing a tuberculin vaccine with cryotherapy for genital warts.
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Facilitating Completion of HPV Vaccination
Clinical trial update describing completion of a study aimed at facilitating HPV vaccination completion among adolescents.
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED) [Phase 3]
A Phase 3 completed trial assessing immunogenicity bridging between an investigational monovalent HPV vaccine and the corresponding componen…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED) [Phase 3]
A completed Phase 3 trial (V501-011) evaluating the safety of Merck's HPV vaccine in women for cervical cancer and genital warts.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: AFIX to Improve HPV Vaccination [NA]
The University of North Carolina, Chapel Hill trial evaluated the AFIX quality-improvement approach to increase HPV vaccination uptake and h…
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years [Phase 3]
This Phase 3 clinical trial update reports immunogenicity and safety data for GlaxoSmithKline's HPV vaccine in healthy women aged 18-35, and…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts [Phase 4]
Phase 4 randomized trial evaluating 400 mg of oral zinc gluconate as adjunctive therapy for genital warts (HPV-related) was terminated.
-
CLINICAL_TRIALS research · 2016-11-01Clinical Trial Update: Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital Warts [Phase 2]
Phase 2 clinical trial update evaluating the safety and efficacy of 15% AS101 Gel for external genital warts, using a double-blind vehicle-c…
-
FDA approval · 2016-08-29FDA Approved: IMIQUIMOD — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Imiquimod submitted by Sun Pharmaceutical Industries. This action typically updates labeling…
-
FDA approval · 2016-07-08FDA Approved: VEREGEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Veregen (sinecatechins) submitted by ANI Pharmaceuticals, Inc., indicating approval of the r…
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine [EARLY_Phase 1]
Phase 1 trial update evaluating whether a patient education/messaging platform increases uptake and completion of the HPV vaccine.
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3 [NA]
A completed clinical trial evaluating reminder prompts to improve completion of HPV vaccine doses 2 and 3 is reported; no study results are …
-
CLINICAL_TRIALS research · 2016-05-10Clinical Trial Update: The Psychosocial and Economic Burden of Genital Warts
This completed clinical trial updates the psychosocial and economic impact of genital warts in women.